RecruitingNCT04751760
Feasibility Study of a New Immunoglobulin E (IgE) Assay Method
Feasibility Study of a New Immunoglobulin E (IgE) Assay Method in Urine and Blood
Sponsor
University Hospital, Toulouse
Enrollment
1,376 participants
Start Date
Apr 20, 2021
Study Type
OBSERVATIONAL
Conditions
Summary
The main objective is to study the feasibility of a new specific IgE assay using a bioluminescence technique in a pediatric and adult allergic population. For this, we will collect blood, and urine during a blood test scheduled for the follow-up of the patient.
Eligibility
Min Age: 6 MonthsMax Age: 99 Years
Inclusion Criteria6
- Males or females 6 months' old or older
- Sensitization or allergy towards a trophallergen, an aeroallergen, hymenoptera venom or drug proven by:
- positive skin test (s)
- and / or IgE specific (s)\> 0.1 kUA / L
- and / or anamnesis in favor of an allergic reaction of mediated IgE
- Social coverage up to date
Exclusion Criteria6
- Children younger than 6 months'old
- Children's weight less than 10 kg
- Pregnant or breastfeeding women
- Patients with cystic fibrosis
- Patients with dysimmune or autoimmune pathology
- Anamnesis in favor of a delayed allergy or a contact allergy.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
BIOLOGICALcollection of blood and urine
blood and urine will be collected during a blood test scheduled for the follow-up of the patient
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04751760